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INTRODUCTION
Antimicrobial resistance is recognized as one of the most serious global threats to human health. These concerns are currently exemplified by the rapid increase in carbapenem-resistant Enterobacteriaceae (Kumarasamy et al. 2010; Munoz-Price et al. 2013) leading to a further limitation of the treatment options for infections caused by these bacteria. As a consequence, older and inconvenient antibiotics such as colistin are being used again in human medicine (Temkin et al. 2014) . However, recently the first plasmid-mediated colistin resistance gene (designated mcr-1) was discovered and has now been shown to occur worldwide (Doumith et al. 2016; Fernandes et al. 2016; Haenni et al. 2016; Irrgang et al. 2016; Liu et al. 2016; Nordmann et al. 2016; Teo et al. 2016; Veldman et al. 2016; El Garch et al. 2017; Lei et al. 2017) . Subsequently, three other colistin resistance genes (mcr-2, mcr-3 and mcr-4) have been reported, further compromising the usefulness of colistin (Xavier et al. 2016b; Carattoli et al. 2017; Yin et al. 2017) .
Although colistin is now an important 'last-line' drug for the treatment of multiple drug-resistant Gram-negative bacterial infections, its major use remains agricultural in pigs and chickens to treat and prevent disease and in some countries also as a growth promotor (Nguyen et al. 2016) . Until its use was discontinued in April 2017, around 8000 tons of colistin was used each year for agriculture in China (Wang et al. 2017) .
Little data are available on colistin resistance in pathogenic Escherichia coli from food-producing animals. In 2016, a study from Belgium showed a high prevalence of mcr-1 and mcr-2 (Xavier et al. 2016a,bbib31) , but no data are available on mcr-3 and mcr-4 in pathogenic E. coli from Belgium (Carattoli et al. 2017) . Here, we investigated the presence of colistin resistance genes (mcr-1, mcr-2, mcr-3) in extraintestinal E. coli from poultry and livestock in China. The sequence for mcr-4 was published following the completion of this study and therefore was not available for our analyses. In addition, we investigated the in vitro maintenance and transfer of mcr-1 between E. coli strains in the absence of colistin.
MATERIALS AND METHODS

Bacterial isolates
We studied 862 distinct clinical isolates of Escherichia coli archived in the Veterinary Microbiology Laboratory of the College of Veterinary Medicine, Yangzhou University. These isolates were recovered between 2004 and 2012 from lung and liver of chickens (n = 644), lung, spleen and liver of pigs (n = 113), milk of cows (n = 61), and liver of ducks (n = 44) from various areas in Jiangsu Province.
DNA extraction
The DNA was extracted from the isolates using the High Pure PCR Template Preparation Kit (Roche Diagnostic, USA) following the manufacturer's instructions.
mcr-1, mcr-2 and mcr-3 qPCRs
The nucleotide sequences of the mcr-1 (E. coli SHP45, KP347127; E. coli KX276657; E. albertii, KX765477; Citrobacter braakii, NZ MTCP01000048; Cronobacter sakazakii, KX505142; Klebsiella pneumoniae, KU761327; Kluyvera ascorbata, KU922754; Salmonella enterica SC23, KU934209; S. enterica Z319S, KX257482), mcr-2 (E. coli, LT598652; Moraxella pluranimalium, MF176239; Moraxella sp., MF176240) and mcr-3 (E. coli, KY924928) were obtained from NCBI (www.ncbi.nlm.nih.gov). Using the Clustal Multiple Alignment Algorithm, we identified conserved 342-bp and 1497-bp regions as targets for the two mcr-1 PCRs we developed (Table 1) . Similarly, we identified highly conserved 282-bp and 576-bp targets for the two mcr-2 PCRs, and 267-bp and 1063-bp targets for the two mcr-3 PCRs we developed (Table 1) . For each gene, the primers we identified for the short target were used in a qPCR while the primers for the longer targets were used in standard PCR.
All PCRs were performed in the LightCycler 480II PCR platform with 10 μl of extracted DNA tested in a 20 μl final volume of reaction mixture. The thermal cycling for the three qPCRs we developed consisted of one activation cycle of 5 min at 95
• C followed by18 high-stringency stepdown cycles, and 35 relaxed-stringency fluorescence acquisition cycles. The 18 highstringency stepdown thermal cycles were 6 × 1 s with a temperature of 95 The specificities of the primers in the qPCRs for the mcr-1, mcr-2 and mcr-3 were verified by BLASTN and also by the size of the PCR products on gel electrophoresis and DNA sequencing of PCR products. The TA Cloning R Kit with pCR2.1 vector (ThermoFisher Scientific) was used to clone the representative PCR products.
The sensitivities of the mcr-1-qPCR, mcr-2-qPCR and mcr-3-qPCR were determined by amplifying dilutions of synthesized plasmids containing portions of the mcr-1, mcr-2 and mcr-3 targets (GenScript, Nanjing, China). The plasmids were linearized with Sac I (Takara Biotechnology, Dalian, China) and quantified using the PicoGreen DNA fluorescence assay (Molecular Probes, Eugene, OR, USA) for preparation of quantitative standards (10 4 , 10 3 , 10 2 , 10 1 , 1 copies/reaction).
Escherichia coli FRET-qPCR
The E. coli FRET-qPCR targeting the gyrA gene was performed as described (Shaheen et al. 2009 ) to differentiate strains based 
Colistin susceptibility testing
A custom-made microdilution susceptibility test was performed in triplicate according to CLSI guidelines and interpretive standards (CLSI 2010). The ATCC 25922 E. coli reference strain (American Tissue Cell Culture, Manassas, VA) was used as control. An isolate was designated as resistant (MIC ≥ 4 μg/ml) or susceptible (MIC ≤ 2 μg/ml) using the guidelines described previously (Hindler and Humphries 2013) ( Table 2 ).
Determination of in vitro maintenance and transfer of mcr-1 in the presence and absence of colistin
We co-cultured a 1:99 mixture of mcr-1-positive E. coli (E249) and mcr-negative E. coli (E254) in Luria-Bertani broth with or without colistin (2 μg/ml) for six passages of 3 h each with aeration. For each passage, a 100 μl of the culture was washed three times in 800 μl of PBS and inoculated into a fresh Luria-Bertani broth. Each passage was incubated for 3 h, representing thus each time approximately 10 generations. After each passage, an aliquot was streaked onto agar plates in triplicate, and 30 colonies were randomly selected from each plate for DNA extraction. The extracted DNA from each bacterial colony was analyzed with the mcr-1 PCR and by gyrA-based FRETqPCR.
Statistical analysis
Confidence intervals were calculated based on the exact binomial distribution using an Excel macro. Prevalence between the different animal species was calculated based on the Chi square test of the Fisher exact test where appropriate. Level of significance was P ≤ 0.05. 
RESULTS
Development of mcr-1-qPCR, mcr-2-qPCR and mcr-3-qPCR
The short targets we detected with our mcr-1-qPCR (342 bp amplicon), mcr-2-qPCR (282 bp) and mcr-3-qPCR (267 bp) (Table 1) were found with the appropriate positive control plasmids at a detection limit of one gene copy per reaction. Each qPCR amplified the plasmids containing its own mcr but did not amplify plasmids containing the other mcr genes. Sequences of amplified amplicons were as expected in each qPCR. The longer The mcr-1-positive E. coli (strain 249) was cultured in broth with or without colistin, for six passages. At the end of each passage, aliquots were streaked onto agar plates in triplicate, and 30 colonies were randomly selected from each plate for DNA extraction and mcr-1 detection by PCR. All bacterial colonies remained mcr-1 positive over six passages, irrespective of whether colistin was present or absent in the culture media.
targets detected in our mcr-1-PCR (1497 bp amplicon), mcr-2-PCR (576 bp amplicon) and mcr-3-PCR (1063 bp amplicon) were also found in the appropriate positive control plasmids with a detection limit of 50 gene copies per reaction.
Prevalence of the mcr-1 in extraintestinal Escherichia coli
Overall, 2.7% (17/624) of the E. coli isolates were positive for the mcr-1. The prevalences did not significantly differ between the different animal species with isolates from chickens (3.2%, CI 1.7-5; 13/404), pigs (0.9%, CI 0-5; 1/113) and ducks (6.8%, CI 1.4-19; 3/44), but no positive isolations from cattle (0/63, CI 0-6). Neither mcr-2 nor mcr-3 was detected in any of the isolates.
Susceptibility testing
While E. coli ATCC strain 25922 and three randomly selected mcr-1-negative isolates from the study were susceptible to colistin, the 17 mcr-1-positive isolates recovered here were resistant to colistin ( Table 2) .
Differentiation of Escherichia coli strain E249 (mcr-1 positive) and E254 (mcr-1 negative) with a gyrA FRET-qPCR
Using FRET-qPCR to amplify the E. coli gyrA in our isolates, we identified a mcr-1-positive E. coli (strain E249) that had a lower T m value (∼60.50
• C) than that of a mcr-1-negative E. coli (strain E254) (∼69.30
• C). Sequencing showed that the mcr-1-positive E. coli strain E249 had two nucleotide mismatches in the gyrA (positions 259 and 264) which resulted in a nine-degree reduction in melting temperature compared to the mcr-1-negative E. coli strain E254 (no gyrA mismatch) and this enabled the ready differentiation of the two strains grown together.
Determination of in vitro maintenance and transfer of mcr-1 in the presence and absence of colistin
After six passages, corresponding to approximately 60 generations of the E. coli strains, all the mcr-1-positive E. coli remained positive for the mcr-1, irrespective of whether colistin was present in the culture media or not (Fig. 1) . In the presence of colistin in the culture media, the percentage of mcr-1-positive E. coli relative to mcr-1-negative E. coli rose rapidly from 1% in generation 0 to 100% in all subsequent passages. In all passages, mcr-1-positive isolates were found, confirming maintenance of the resistance in the presence of MIC concentrations of colistin (Fig. 2) .
In the absence of colistin in the media, the percentage of colonies of mcr-1-positive E. coli relative to mcr-1-negative E. coli did not increase and remained low (under 3%) through all the passages studied. The 3% of the E. coli were mcr-1 positive in each passage, compared to the initial 1% (Fig. 2) . The mcr-1 qPCR followed by melting temperature analysis and DNA sequencing identified eight mcr-1-positive colonies: four were the E. coli strain 249 that was originally positive for the mcr-1 and four (50%) were the E. coli strain 254 that did not contain the mcr-1 at the beginning of the experiment. This indicates that there was a transfer of the mcr-1 containing plasmid from E. coli strain 249 to E. coli strain 254 while they were co-cultured in the absence of colistin.
DISCUSSION
Few investigations have looked for colistin resistance in pathogenic Escherichia coli from animals, and even less data are available on their colistin susceptibility, as regular disk diffusion tests, used in many clinical veterinary laboratories, do not allow accurate detection of resistance. This report provides comprehensive data on the prevalence of colistin resistance genes in extraintestinal E. coli isolates from poultry and livestock in China. We found no differences in mcr prevalence between different animal species; however, this may be due to the small sample size for some animal species. The mcr-2 plasmid-mediated colistin resistance determinant was identified for the first time in E. coli from pigs and cattle in Belgium (Xavier et al. 2016b) . In a subsequent retrospective survey of 58 German pig-fattening farms (Roschanski et al. 2017) , the mcr-1 was found in 9.9% of 436 samples and 25.9% of the farms while the mcr-2 was not detected (Roschanski et al. 2017) . Also, the mcr-2 could not be identified in almost 10 000 animal/clinical samples from China (Sun et al. 2017) . We could also not identify the mcr-2 in this study in China.
The third mobile colistin resistance gene, mcr-3, was first described in E. coli from pigs in China (Doumith et al. 2016) . Then, mcr-3 or mcr-3 variants were detected in low prevalence from E. coli recovered from bloodstream infections in Denmark (Roer et al. 2017) , human Salmonella from Denmark (Litrup et al. 2017) , bovine E. coli in Spain (Hernández et al. 2017) and Aeromonas veronii from chickens in China (Ling et al. 2017 ). We did not find the mcr-3 gene in our extraintestinal E. coli isolates that indicates a very low prevalence or absence altogether.
Since 1 April 2017, the Chinese government has implemented the withdrawal of colistin as a food additive for growth promotion in food animal (Wang et al. 2017 ). This appears appropriate as studies have demonstrated high levels of the mcr-1 in China (Liu et al. 2016; Huang et al. 2017; Wang et al. 2017; Wang et al. 2017a,b) . These high prevalences may be explained by the strong selection pressure for the mcr-1 we identified in our E. coli passage experiments. The percentage of E. coli with the mcr-1 relative to those without the gene rose from an initial 1% to 100% in one passage.
Following the withdrawal of colistin, we were interested in how long mcr may remain in the population. There is currently no data on the fate of the mcr-1-positive bacteria once there is no longer selection pressure from colistin. Therefore, we performed in vitro stability and horizontal gene transfer studies of mcr-1 in E. coli. We chose shorter incubation periods with a lower concentration of resistant strains compared with many other studies to better reflect the actual environment with a low mcr prevalence. Our findings demonstrate that the colistin resistance gene is maintained at an unchanged level through 60 generations in the absence of colistin, and that transfer occurs even in the absence of selective pressure by colistin. The latter has also been demonstrated for extended-spectrum beta-lactamases (ESBLs) (Smet et al. 2011) . A 2% increase in mcr-1-positive E. coli in the absence of colistin may suggest that the resistance is stable and may still transfer even when colistin removed from food animal production (Jørgensen et al. 2017) . The viability of the strains compared to the other strains could not be determined, though the transfer experiment shows that there is likely no competition between those two strains. Further close monitoring of the mcr gene in bacteria as the colistin withdrawal is completed in China is indicated to see if this will be the case and provide further data on the effects of lessened antimicrobial use and its effects on antibiotic resistance in bacteria in animals and the environment.
In conclusion, our data show the prevalence, albeit low, of mcr in animal extraintestinal E. coli. Moreover, our data demonstrate that mcr-1 is readily transmitted between bacteria and is well maintained in vitro, even without the selective pressure of colistin.
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